Skip to Content
Merck
CN
  • Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.

Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.

Nephrology (Carlton, Vic.) (2013-02-26)
Tony K Kwan, Steve J Chadban, Paul R McKenzie, John R Saunders
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Oxalic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
Oxalic acid, 98%
Sigma-Aldrich
Oxalic acid, purified grade, 99.999% trace metals basis
Supelco
Oxalic acid concentrate, 0.1 M (COOH)2 (0.2N), eluent concentrate for IC
Sigma-Aldrich
Oxalic acid, puriss. p.a., anhydrous, ≥99.0% (RT)
Supelco
Sodium oxalate, reference material for titrimetry, certified by BAM, >99.5%
Sigma-Aldrich
Sodium oxalate, BioXtra
Sigma-Aldrich
Sodium oxalate, ≥99.99% trace metals basis
Sigma-Aldrich
Sodium oxalate, puriss. p.a., ACS reagent, ≥99.5% (RT)
Sigma-Aldrich
Sodium oxalate, ACS reagent, ≥99.5%